UCSF Bay Area Biotechnology Symposium, Pharmaceuticals for the Future

This is not a Bay Area LifeTech event, but I thought this excellent lineup of speakers would be of interest to members...

Bay Area Biotechnology Symposium, Pharmaceuticals for the Future: Problems and Solutions

http://calendar.ucsf.edu/event/24225/

Mission Bay

9:00 AM- 1:00 PM

Saturday, May 19, 2012 Description:

We have assembled leading scientists from San Francisco Bay Area biotechnology companies who will each share a story of how their company took an idea, developed it, and transformed it into a therapeutic. You will hear speakers from Amgen, Genentech, Gilead, Bayer, Nektar, and Rinat (Pfizer) and learn about drug development at these companies and the associated challenges. There is no charge and no pre-registration.

AGENDA

9:15 Alexander Kamb, Ph.D. Senior Vice President of Research, Amgen “A Stronger Spine: Lessons from an Innovative Bone Drug “

9:45 Stephen K. Doberstein, Ph.D. Senior Vice President, Nektar Therapeutics “Smart Pharmacology: Putting Active Drugs in the Right Place at the Right Time”

10:20 David Cox M.D., Ph.D. Senior Vice President, Rinat/Pfizer “Human Genetics, Precision Medicine and Improved Health Outcomes”

10:55- coffee break

11:15 John Murphy, Ph.D. Director, Molecular Biology and Protein Expression, Bayer HealthCare “Engineering post-translational modifications to improve efficacy of recombinant Factor VIIa”

11:50 Randall Halcomb, Ph.D. Director of Medicinal Chemistry, Gilead Sciences “Discovery of GS-9620, an oral agonist of Toll-like receptor 7 for the treatment of chronic hepatitis B and C infection"

12:25 Fred deSauvage, Ph.D. Vice President of Research, Molecular Biology, Genentech “Development of a Hedgehog Pathway Inhibitor for the treatment of Basal Cell Carcinoma”